Physician
Pulmonology
Dr. Jonathan M. Edelman, MD
|
|
Give Review
Dr. Jonathan M. Edelman is an expert in the field of Pulmonology. He graduated from Icahn School of Medicine at Mount Sinai. Icahn School of Medicine at Mount Sinai has a rank of 20 in research and a 62 in primary care Jonathan Edelman is a published doctor and has 52 publications published. The lastest was: 'A study of losartan, alone or with hydrochlorothiazide vs nifedipine GITS in elderly patients with diastolic hypertension.'
Publications
- The Back to School asthma study: the effect of montelukast on asthma burden when initiated prophylactically at the start of the school year.
- Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients.
- Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study.
- Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
- ADVANTAGE: Merck does say "no".
- ADVANTAGE: science first, marketing second.
- Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.
- Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.
- Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies.
- Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
- Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertensi...
- Pharmacokinetics of indinavir and ritonavir administered at 667 and 100 milligrams, respectively, every 12 hours compared with indinavir administered at 800 milligrams...
- Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
- Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
- Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study.
- Evaluation of parental preference for the treatment of asthmatic children aged 6 to 11 years with oral montelukast or inhaled cromolyn: a randomized, open-label, cross...
- Effects of montelukast and beclomethasone on airway function and asthma control.
- Asthma control and patient satisfaction among early pediatric users of montelukast.
- Influence of body mass index on the response to asthma controller agents.
- A study of losartan, alone or with hydrochlorothiazide vs nifedipine GITS in elderly patients with diastolic hypertension.
- Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patient...
- Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function.
- Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial a...
- Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
- Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension.
- Cathepsin B and D activity in alveolar macrophages from rats with pulmonary granulomatous inflammation or acute lung injury.
- Lipopolysaccharide stimulates alveolar macrophage adherence in vivo and in vitro.
- The effect of intra-articular steroids on plasma salicylate concentrations.
- Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study.
- All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertro...
- Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study.
- Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension st...
- Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hyperten...
- Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losar...
- Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
- Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
- Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients.
- Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy.
- The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint R...
- Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.
- A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge.
- Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
- Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
- Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) St...
- Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.
- Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study.
- Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group.
- Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention...
- Population impact of losartan use on stroke in the European Union (EU): projections from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
- Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone.
- Variability of symptoms in mild persistent asthma: baseline data from the MIAMI study.
Schools
Mount Sinai School of Medicine
Doctors Specialties
- Pulmonology
Accepted Insurances
Education
-
University of Pennsylvania Health System -
Mount Sinai School of Medicine -
Icahn School of Medicine at Mount Sinai
Helpful Reviews
Similar Doctors
|
|
Philip E. Silkoff, MB |
|
|
Dr. Joanne E. Getsy, MD
 This Doctor is OpenDoctor Recommended.
|